Rehovot-based Evogene develops genetically enhanced seeds to elevate crop performance and productivity.
Evogene Ltd. (TASE:EVGN) has filed a registration statement with the US Securities and Exchange Commission (SEC) to raise $60 million in a public offering on the New York Stock Exchange. The company has not disclosed the terms of the proposed offering.
Rehovot-based Evogene develops genetically enhanced seeds to elevate crop performance and productivity. It posted $18 million revenue in the 12 months through June 2013.
Credit Suisse Securities and Deutsche Bank Securities LLC are the joint book-running managers for the proposed offering, and Oppenheimer & Co. and Piper Jaffray & Co. are the co-managers.
Published by Globes [online], Israel business news - www.globes-online.com - on September 24, 2013
© Copyright of Globes Publisher Itonut (1983) Ltd. 2013